MacroGenics Inc (MGNX) income statement
MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96−0.02 (-1.01%)
Close on Nov 20, 2026Market cap $124.85MP/E –Yield –
MacroGenics Inc financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $124.85MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||||||
| Gross margin | 100.0% | 99.4% | 98.9% | 97.8% | 96.6% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – |
| Operating margin | -48.7% | -73.7% | -286.4% | -79.9% | -261.9% | -125.0% | -276.0% | -284.8% | -14.0% | -65.3% | -20.0% | -80.2% | 0.63% | 12.9% | 9.2% | – |
| EBITDA margin | -43.9% | -68.7% | -270.0% | -72.1% | -247.3% | -113.6% | -256.9% | -269.5% | -9.5% | -57.1% | -17.2% | -76.3% | 2.7% | 14.4% | 11.1% | – |
| Pre-tax margin | -50.4% | -44.0% | -15.4% | -78.8% | – | – | – | – | – | – | – | – | – | – | – | – |
| Net profit margin | -49.9% | -44.7% | -15.4% | -78.8% | -261.0% | -123.7% | -236.5% | -285.2% | -12.4% | -63.7% | -20.0% | -80.2% | -0.45% | 13.1% | 11.7% | – |
| Free cash flow margin | -55.5% | -48.1% | -136.1% | -59.6% | -193.7% | -112.3% | -215.9% | -296.4% | -9.5% | -59.9% | -22.7% | -76.0% | -29.5% | -11.8% | 10.9% | – |
| Returns on capital | ||||||||||||||||
| Return on equity | -86.9% | -49.9% | -6.1% | -62.8% | -75.5% | -49.3% | -64.1% | -63.3% | -6.9% | -20.1% | -9.3% | -38.3% | -0.74% | -65.0% | -23.9% | – |
| Return on assets | -28.8% | -23.9% | -3.1% | -38.9% | -56.6% | -37.5% | -47.1% | -48.6% | -5.7% | -17.5% | -7.6% | -25.6% | -0.29% | 15.6% | – | – |
| Return on tangible assets | -28.8% | -23.9% | -3.1% | -38.9% | -56.6% | -37.5% | -47.1% | -48.6% | -5.7% | -17.5% | -7.6% | -25.6% | -0.29% | 15.6% | – | – |
| Return on capital employed | -34.7% | -49.3% | -71.0% | -49.3% | -68.9% | -44.0% | -65.7% | -57.4% | -7.3% | -19.4% | -8.4% | -31.4% | 0.61% | 34.2% | – | – |
| NOPAT | -$57.54M | -$87.36M | -$132.91M | -$95.92M | -$160.21M | -$103.54M | -$139.98M | -$135.25M | -$17.49M | -$47.43M | -$15.94M | -$30.27M | $289.14K | $6.48M | $4.15M | – |
| Cash flow quality | ||||||||||||||||
| OCF / Sales | -54.2% | -45.6% | -133.1% | -57.2% | -185.7% | -106.7% | -209.2% | -254.9% | 9.1% | -47.5% | -13.5% | -68.5% | -24.4% | -10.3% | 11.8% | – |
| OCF / Net income | 1.09 | 1.02 | 8.63 | 0.73 | 0.71 | 0.86 | 0.88 | 0.89 | -0.73 | 0.75 | 0.68 | 0.86 | 54.30 | -0.79 | 1.01 | – |
| FCF / OCF | 102.4% | 105.4% | 102.3% | 104.2% | 104.3% | 105.3% | 103.2% | 116.3% | -104.1% | 126.1% | 167.3% | 110.9% | 120.9% | 114.3% | 92.6% | – |
| FCF / Net income | 1.11 | 1.08 | 8.83 | 0.76 | 0.74 | 0.91 | 0.91 | 1.04 | 0.76 | 0.94 | 1.13 | 0.95 | 65.64 | -0.90 | 0.93 | – |
| FCF / EBITDA | 126.3% | 70.0% | 50.4% | 82.7% | 78.3% | 98.9% | 84.0% | 110.0% | 100.6% | 105.0% | 132.0% | 99.6% | -1,094.1% | -81.7% | 98.5% | – |
| Unlevered free cash flow | -$76.23M | -$71.20M | -$78.84M | -$90.58M | -$150.03M | -$117.80M | -$138.56M | -$178.19M | -$15.00M | -$55.06M | -$22.86M | -$36.33M | -$17.13M | -$7.52M | $6.26M | – |
| Levered free cash flow | -$82.95M | -$72.08M | -$79.97M | -$90.58M | -$150.03M | -$117.80M | -$138.56M | -$178.19M | -$15.00M | -$55.06M | -$22.86M | -$36.33M | -$17.13M | -$7.52M | $6.26M | – |
| Efficiency | ||||||||||||||||
| Asset turnover | 0.58 | 0.54 | 0.20 | 0.49 | 0.22 | 0.30 | 0.20 | 0.17 | 0.46 | 0.27 | 0.38 | 0.32 | 0.65 | 1.19 | – | – |
| Fixed asset turnover | 14.80 | 7.51 | 2.28 | 4.52 | 1.94 | 2.32 | 1.22 | 1.13 | 4.64 | 5.60 | 9.33 | 8.09 | 13.98 | 19.53 | – | – |
| Receivables turnover | 63.13 | 20.44 | 1.76 | 4.56 | 4.63 | 5.86 | 3.03 | 2.78 | 19.23 | 46.08 | 48.50 | 19.35 | 28.66 | 31.19 | – | – |
| Days sales outstanding | 5.8 | 17.9 | 206.9 | 80.0 | 78.9 | 62.3 | 120.3 | 131.2 | 19.0 | 7.9 | 7.5 | 18.9 | 12.7 | 11.7 | – | – |
| Payables turnover | 0.00 | 0.15 | 0.11 | 0.33 | 0.23 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – |
| Days payables outstanding | – | 2,468.4 | 3,344.0 | 1,111.0 | 1,619.9 | – | – | – | – | – | – | – | – | – | – | – |
| Inventory turnover | 0.00 | 1.39 | 0.46 | 1.15 | 1.21 | – | – | – | – | – | – | – | – | – | – | – |
| Days inventory outstanding | – | 263.1 | 787.8 | 318.0 | 302.1 | – | – | – | – | – | – | – | – | – | – | – |
| Operating cycle | – | 280.9 | 994.6 | 398.0 | 380.9 | – | – | – | – | – | – | – | – | – | – | – |
| Cash conversion cycle | – | -2,187.4 | -2,349.3 | -713.0 | -1,239.0 | – | – | – | – | – | – | – | – | – | – | – |
| CapEx to revenue | 1.3% | 2.5% | 3.0% | 2.4% | 8.0% | 5.6% | 6.7% | 41.5% | 18.6% | 12.4% | 9.1% | 7.5% | 5.1% | 1.5% | 0.87% | – |
| CapEx to OCF | -2.4% | -5.4% | -2.3% | -4.2% | -4.3% | -5.3% | -3.2% | -16.3% | 204.1% | -26.1% | -67.3% | -10.9% | -20.9% | -14.3% | 7.4% | – |
| CapEx to depreciation | 0.27 | 0.49 | 0.18 | 0.31 | 0.55 | 0.49 | 0.35 | 2.72 | 4.07 | 1.50 | 3.21 | 1.96 | 2.47 | 0.94 | 0.45 | – |
| Liquidity | ||||||||||||||||
| Current ratio | 5.10 | 3.92 | 4.48 | 4.57 | 3.75 | 6.17 | 5.31 | 4.49 | 6.48 | 10.40 | 14.15 | 6.08 | 4.14 | 1.68 | – | – |
| Quick ratio | 4.92 | 3.92 | 4.46 | 4.54 | 3.69 | 6.17 | 5.31 | 4.49 | 6.48 | 10.40 | 14.15 | 6.08 | 4.14 | 1.68 | – | – |
| Cash ratio | 1.33 | 3.29 | 1.80 | 2.24 | 1.66 | 3.57 | 2.80 | 3.67 | 4.26 | 3.08 | 8.11 | 5.82 | 4.04 | 1.61 | – | – |
| Working capital | $176.83M | $161.96M | $195.23M | $173.57M | $204.98M | $261.92M | $194.62M | $209.18M | $272.54M | $256.65M | $318.18M | $137.64M | $90.64M | $20.20M | – | – |
| Net current asset value | $18.69M | $71.89M | $105.53M | $83.73M | $183.93M | $229.74M | $157.91M | $179.87M | $247.65M | $241.44M | $296.45M | $112.14M | $72.59M | -$12.06M | – | – |
| Leverage | ||||||||||||||||
| Assets to equity | 4.62 | 2.25 | 1.96 | 1.97 | 1.40 | 1.28 | 1.36 | 1.37 | 1.25 | 1.16 | 1.15 | 1.43 | 1.59 | -6.52 | – | – |
| Interest coverage | ||||||||||||||||
| EBIT / Interest expense | -8.56 | -99.17 | -117.65 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EBITDA / Interest expense | -7.72 | -92.41 | -110.91 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| (EBITDA − CapEx) / Interest expense | -7.94 | -95.73 | -112.14 | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Per share | ||||||||||||||||
| Revenue per share | 2.36 | 2.39 | 0.95 | 2.46 | 1.26 | 1.86 | 1.31 | 1.42 | 4.28 | 2.63 | 2.94 | 1.71 | 2.31 | 58.08 | 55.78 | – |
| EPS (basic) | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 | – | – | -0.54 | -1.69 | -0.63 | -1.40 | -0.04 | 0.00 | 0.00 | – |
| EPS (diluted) | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 | – | – | -0.54 | -1.69 | -0.63 | -1.40 | -0.04 | 0.00 | 0.00 | – |
| Book value per share | 0.88 | 1.85 | 2.46 | 2.30 | 3.91 | 5.26 | 4.71 | 5.73 | 8.12 | 7.71 | 9.12 | 4.33 | 3.13 | -7.50 | -17.05 | – |
| Tangible book value per share | 0.88 | 1.85 | 2.46 | 2.30 | 3.91 | 5.26 | 4.71 | 5.73 | 8.12 | 7.71 | 9.12 | 4.33 | 3.13 | -7.50 | -17.05 | – |
| Cash per share | 0.90 | 2.91 | 1.63 | 1.76 | 2.01 | 3.22 | 2.58 | 5.20 | 5.74 | 2.41 | 5.71 | 5.63 | 4.63 | 43.45 | 53.84 | – |
| Operating cash flow per share | -1.28 | -1.09 | -1.26 | -1.41 | -2.35 | -1.99 | -2.74 | -3.62 | 0.39 | -1.25 | -0.40 | -1.17 | -0.56 | -5.99 | 6.59 | – |
| Free cash flow per share | -1.31 | -1.15 | -1.29 | -1.47 | -2.45 | -2.09 | -2.83 | -4.21 | -0.41 | -1.58 | -0.67 | -1.30 | -0.68 | -6.84 | 6.10 | – |
| CapEx per share | 0.03 | 0.06 | 0.03 | 0.06 | 0.10 | 0.11 | 0.09 | 0.59 | 0.80 | 0.33 | 0.27 | 0.13 | 0.12 | 0.86 | 0.49 | – |
| Valuation at period end | ||||||||||||||||
| Market cap | $101.85M | $203.98M | $596.72M | $412.41M | $983.14M | $1.28B | $532.19M | $536.55M | $699.34M | $711.58M | $1.06B | $973.97M | $58.28M | – | – | – |
| Enterprise value | $21.72M | $24.36M | $506.82M | $328.42M | $792.61M | $1.08B | $375.59M | $334.74M | $608.45M | $601.68M | $694.90M | $794.78M | $24.71M | – | – | – |
| P/S | 0.7x | 1.4x | 10.2x | 2.7x | 12.7x | 12.2x | 8.3x | 8.9x | 4.4x | 7.7x | 10.5x | 20.4x | 1.0x | – | – | – |
| P/B | 1.8x | 1.8x | 3.9x | 2.9x | 4.1x | 4.3x | 2.3x | 2.2x | 2.3x | 2.6x | 3.4x | 8.0x | 0.7x | – | – | – |
| P/TBV | 1.8x | 1.8x | 3.9x | 2.9x | 4.1x | 4.3x | 2.3x | 2.2x | 2.3x | 2.6x | 3.4x | 8.0x | 0.7x | – | – | – |
| P/Gross profit | 0.7x | 1.4x | 10.3x | 2.8x | 13.1x | 12.2x | 8.3x | – | – | – | – | – | – | – | – | – |
| P/OCF | -1.3x | -3.0x | -7.6x | -4.7x | -6.8x | -11.5x | -4.0x | -3.5x | 48.5x | -16.3x | -77.6x | -29.7x | -4.1x | – | – | – |
| EV/Sales | 0.1x | 0.2x | 8.6x | 2.2x | 10.2x | 10.3x | 5.9x | 5.6x | 3.9x | 6.5x | 6.9x | 16.6x | 0.4x | – | – | – |
| EV/Gross profit | 0.1x | 0.2x | 8.7x | 2.2x | 10.6x | 10.3x | 5.9x | – | – | – | – | – | – | – | – | – |
| EV/EBITDA | – | – | – | – | – | – | – | – | – | – | – | – | 15.8x | – | – | – |
| EV/EBIT | – | – | – | – | – | – | – | – | – | – | – | – | 67.5x | – | – | – |
| EV/OCF | -0.3x | -0.4x | -6.5x | -3.8x | -5.5x | -9.7x | -2.8x | -2.2x | 42.2x | -13.8x | -50.9x | -24.3x | -1.7x | – | – | – |
| Earnings yield | -73.3% | -32.8% | -1.5% | -29.0% | -20.6% | -10.1% | -28.5% | -32.0% | -2.8% | -8.2% | -1.9% | -3.9% | -0.45% | – | – | – |
| FCF yield | -81.5% | -35.3% | -13.4% | -22.0% | -15.3% | -9.2% | -26.0% | -33.2% | -2.1% | -7.7% | -2.2% | -3.7% | -29.4% | – | – | – |
| Cost structure | ||||||||||||||||
| R&D to revenue | 98.4% | 118.2% | 283.6% | 136.3% | 277.1% | 184.2% | 304.3% | 317.4% | 93.3% | 132.9% | 97.4% | 146.8% | 80.3% | 71.2% | 71.8% | – |
| Stock-based comp to revenue | 9.6% | 19.6% | 31.3% | 13.5% | 29.9% | 19.7% | 30.5% | 27.5% | 9.3% | 13.2% | 7.8% | 6.8% | 1.5% | 1.3% | 4.1% | – |
| Per employee | ||||||||||||||||
| Total employees | 293 | 341 | 339 | 357 | 427 | 370 | 384 | 364 | 330 | 318 | 269 | 211 | 166 | 166 | 166 | 166 |
| Revenue per employee | $510.24K | $439.77K | $173.30K | $425.61K | $181.37K | $283.47K | $167.16K | $165.17K | $478.01K | $288.93K | $374.92K | $226.53K | $349.61K | $384.49K | $344.62K | – |
| Gross profit per employee | $510.24K | $437.29K | $171.47K | $416.22K | $175.17K | $283.47K | $167.16K | – | – | – | – | – | – | – | – | – |
| Operating profit per employee | -$248.60K | -$324.28K | -$496.29K | -$340.11K | -$474.93K | -$354.22K | -$461.42K | -$470.35K | -$67.10K | -$188.81K | -$75.03K | -$181.59K | $2.20K | $49.43K | $31.62K | – |
| Net income per employee | -$254.68K | -$196.38K | -$26.72K | -$335.46K | -$473.34K | -$350.65K | -$395.34K | -$471.02K | -$59.47K | -$184.05K | -$74.87K | -$181.58K | -$1.57K | $50.37K | $40.46K | – |
| Free cash flow per employee | -$283.12K | -$211.38K | -$235.90K | -$253.73K | -$351.36K | -$318.39K | -$360.83K | -$489.53K | -$45.45K | -$173.14K | -$84.97K | -$172.18K | -$103.21K | -$45.31K | $37.69K | – |
| Growth | ||||||||||||||||
| Revenue 1Y growth | -0.31% | 155.3% | -61.3% | 96.2% | -26.2% | 63.4% | 6.8% | -61.9% | 71.7% | -8.9% | 111.0% | -17.6% | -9.1% | 11.6% | – | – |
| Revenue 3Y CAGR | -0.54% | 24.6% | -17.6% | 33.3% | 8.8% | -12.7% | -11.3% | -15.8% | 48.9% | 16.5% | 16.5% | -5.8% | – | – | – | – |
| Revenue 5Y CAGR | 7.3% | 18.5% | -0.46% | -0.75% | -3.4% | 0.79% | 6.1% | 0.71% | 19.8% | 9.9% | – | – | – | – | – | – |
| Revenue 10Y CAGR | 4.0% | 12.1% | 0.12% | 9.1% | 3.1% | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | 0.26% | 156.5% | -60.9% | 98.7% | -28.7% | 63.4% | – | – | – | – | – | – | – | – | – | – |
| Gross profit 3Y CAGR | 0.20% | 25.9% | -17.9% | 32.3% | – | – | – | – | – | – | – | – | – | – | – | – |
| Gross profit 5Y CAGR | 7.3% | 18.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 34.1% | 34.3% | -38.6% | 40.1% | -54.7% | 26.0% | -3.5% | -673.2% | 63.1% | -197.5% | 47.3% | -10,568.6% | -95.5% | 56.3% | – | – |
| EBITDA 1Y growth | 36.3% | 35.0% | -44.8% | 42.8% | -60.8% | 27.8% | -1.7% | -986.5% | 71.6% | -202.8% | 52.5% | -2,430.3% | -83.0% | 45.0% | – | – |
| Net income 1Y growth | -11.4% | -639.3% | 92.4% | 40.7% | -55.8% | 14.5% | 11.5% | -773.6% | 66.5% | -190.6% | 47.4% | -14,579.3% | -103.1% | 24.5% | – | – |
| Diluted EPS 1Y growth | -10.3% | -613.3% | 92.3% | 42.1% | -36.4% | – | – | – | 68.0% | -168.3% | 55.0% | -3,400.0% | – | – | – | – |
| Operating cash flow 1Y growth | -18.5% | 12.6% | 10.1% | 39.5% | -28.5% | 16.7% | 12.4% | -1,163.8% | 133.0% | -219.7% | 58.3% | -131.2% | -115.3% | -197.4% | – | – |
| Free cash flow 1Y growth | -15.1% | 9.9% | 11.7% | 39.6% | -27.4% | 15.0% | 22.2% | -1,088.1% | 72.8% | -140.9% | 37.1% | -112.1% | -127.8% | -220.2% | – | – |
| CapEx 1Y growth | -48.4% | 110.1% | -51.3% | -41.6% | 5.0% | 37.7% | -82.8% | -15.1% | 158.4% | 23.7% | 157.5% | 20.6% | 215.0% | 87.9% | – | – |
| CapEx 3Y CAGR | -19.2% | -15.8% | -33.2% | -5.5% | -37.1% | -41.4% | -27.8% | 39.5% | 101.9% | 56.6% | 113.9% | 92.6% | – | – | – | – |
| CapEx 5Y CAGR | -20.2% | -2.9% | -41.1% | -34.2% | -11.4% | -8.5% | 3.7% | 53.2% | 99.1% | 86.8% | – | – | – | – | – | – |
| CapEx 10Y CAGR | -14.5% | 0.37% | -5.0% | 14.4% | 28.6% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -1.8% | -12.3% | 6.4% | -16.3% | -11.5% | 21.2% | -5.9% | -11.2% | 20.1% | -13.4% | 106.6% | 38.2% | 134.0% | – | – | – |
| Total assets 3Y CAGR | -2.9% | -7.9% | -7.6% | -3.5% | 0.31% | 0.43% | 0.13% | -2.6% | 29.1% | 35.3% | 88.4% | – | – | – | – | – |
| Total assets 5Y CAGR | -7.5% | -3.5% | -2.1% | -5.6% | 1.5% | 1.1% | 12.4% | 21.4% | 47.4% | – | – | – | – | – | – | – |
| Total assets 10Y CAGR | -3.3% | 4.2% | 9.0% | 18.0% | – | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -52.1% | -24.0% | 7.5% | -40.7% | -19.0% | 28.3% | -5.0% | -18.8% | 11.3% | -14.2% | 158.3% | 53.7% | 1,057.9% | 52.9% | 54.7% | – |
| Total equity 3Y CAGR | -26.8% | -21.5% | -19.8% | -14.9% | -0.45% | -0.38% | -5.0% | -8.1% | 35.1% | 50.5% | – | – | – | – | – | – |
| Total equity 5Y CAGR | -28.4% | -12.8% | -8.9% | -13.8% | -2.3% | -1.1% | 13.7% | 25.2% | – | – | – | – | – | – | – | – |
| Total equity 10Y CAGR | -15.9% | -0.44% | 6.8% | – | – | – | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.